Acne

Dermatologists are using an evolving collection of combination therapies designed to address different aspects of disease, monotherapy limitations and failures, as well as enhance treatment.

Dermatologists generally know that the sensitivity of many pathogens to the antibiotics used to treat them is decreasing, experts say. But many dermatologists may not appreciate their specialty’s role in potentially fueling the problem.

Popular media coverage of purported links between isotretinoin and inflammatory bowel disease (IBD) are largely overblown, as are patients’ concerns regarding the risks of oral contraceptive pills (OCPs) for acne, according to an expert.

Even though bacteria such as Propionibacterium acnes share the same genus and species, says an expert, recent research suggests that different P. acnes strains may behave differently, which could have profound implications for acne treatment.

With isotretinoin disappearing from continuous medical education (CME), says an expert, dermatologists must take the initiative in promoting best practices for this indispensable acne drug.

Women and men are not always created equal when it comes to their dermatologic concerns, frequency and presentation of several dermatologic conditions, treatment options and outcomes.

ArteFill (Suneva Medical) may fill a void in the long-term treatment of acne scarring, initial study data indicates.

Even though patients may present with clinically similar acne, says an expert, their expectations and preferences for particular treatments may differ vastly.

With acne presenting in increasingly younger patients, new guidelines developed by the American Acne and Rosacea Society (AARS) promote more consistent care for pediatric patients, according to an expert.

While topical and oral therapies remain the gold standard approach for treating acne, laser and light sources are effective for acne lesions and scarring, and can be particularly useful in cases recalcitrant to standard therapeutic approaches.

Recent developments regarding acne and rosacea in skin of color include studies showing that combination topical products for acne appear safe in this population, and the fact that rosacea is perhaps more prevalent than many might expect.

Clinicians can sift facts from fiction on diseases such as acne by checking Twitter, a letter by Boston-based Center for Connected Health researchers suggests.

Newly released expert recommendations from the American Acne and Rosacea Society are the first evidence-based clinical guidelines for the management of acne vulgaris in children and adolescents.

Promius Pharma has launched Zenatane (isotretinoin) capsules for the treatment of acne vulgaris.

Dermatologists’ prescribing of oral contraceptive pills (OCPs) and antibiotics for acne leaves room for improvement, according to an expert.

The Food and Drug Administration has approved the topical acne drug Epiduo (adapalene 01. percent/benzoyl peroxide 2.5 percent, Galderma) in children ages 9 and older, according to a news release.

Acne scars are potentially socially debilitating lifelong reminders of the condition. Fortunately, modern laser therapy allows dermatologists to offer their patients hope for improvement. Prior to initiating laser therapy for acne scars it is important to consider the types of scars encountered.

A microneedle radiofrequency (RF) device was as effective for acne vulgaris as a carbon dioxide (CO2) laser, but with less downtime, according to findings from a recent study.

Revolutionized by the advent of fractional laser technology, laser surgery for scars continues to evolve. However, clinicians continue to be confronted with a wide variety of scar types without a well-established treatment algorithm.

Ranbaxy is launching its isotretinoin product for the treatment of acne, Absorica, in the United States.

Low-dose isotretinoin may be effective, with fewer side effects, when used to treat adult acne, results of a clinical trial presented at the annual congress of the European Academy of Dermatology and Venereology suggest.

A new study involving cross-sectional samples of the U.S. population reveals no association between isotretinoin and suicidality, the study-s author says.